Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCT
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Hematology"
DOI: 10.1007/s00277-019-03864-y
Abstract: Ruxolitinib is a promising option for treating steroid-refractory acute graft-versus-host disease (SR-aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In this study, we describe ruxolitinib treatment for SR-aGVHD in HSCT patients with Epstein-Barr virus-associated hemophagocytic… read more here.
Keywords: agvhd; ruxolitinib; patients ebv; treatment ... See more keywords
Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-116738
Abstract: Background Diffuse large B cell lymphoma post-transplant lymphoproliferative disorder (DLBCL-PTLD) represents a fatal complication after a solid organ transplant (SOT). Approximately 50% of DLBCL-PTLD can be related to Epstein Barr Virus (EBV) infection. However, the… read more here.
Keywords: status; ebv positive; patients ebv; dlbcl ptld ... See more keywords
Clinical features of nervous system disorders in patients with EBV as monoinfection and in association with other herpes viruses in their reactivation and persistence
Sign Up to like & getrecommendations! Published in 2018 at "Artificial Intelligence"
DOI: 10.22141/2312-413x.5.6.2017.122136
Abstract: Під спостереженням перебувало 48 хворих з ураженнями нервової системи, викликаними вірусами Епштейна — Барр (EBV) у моноінфекції або в асоціації з іншими вірусами родини герпесу при їх реактивації або персистенції. При активації EBV-інфекції найчастіше діагностується… read more here.
Keywords: features nervous; clinical features; nervous system; patients ebv ... See more keywords